Tricida (TCDA) Misses Q4 EPS by 24c

Tricida (NASDAQ: TCDA) reported Q4 EPS of ($0.92), $0.24 worse than the analyst estimate of ($0.68).

Tricida currently has the financial resources to fund its planned operations into early in the second quarter of 2023, which is anticipated to be approximately six months from the announcement of its top-line results for the VALOR-CKD trial.

For earnings history and earnings-related data on Tricida (TCDA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
• KULR Technology Group (KULR) Misses Q2 EPS by 39c